Broadening the Genetic Spectrum of Painful Small-Fiber Neuropathy through Whole-Exome Study in Early-Onset Cases
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137248 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kaalindi Misra und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Genetics of Neurological Disorders, IRCCS San Raffaele Scientific Institute, Institute of Experimental Neurology, 20132 Milan, It…. Hauptthemen laut MEDLINE: Exome Sequencing, Small Fiber Neuropathy, Age of Onset. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Molecule-to-Man Pain Network, a European Commission Multi-Center Collaborative Projects through the European Union's Horizon 2020 research and innovation progr…, European Union seventh framework program for the PROPANE study, Italian Ministry of Health.
Abstract (Originalsprache)
Small-Fiber Neuropathy (SFN) is a disorder of the peripheral nervous system, characterised by neuropathic pain; approximately 11% of cases are linked to variants in Voltage-Gated Sodium Channels (VGSCs). This study aims to broaden the genetic knowledge on painful SFN by applying Whole-Exome Sequencing (WES) in Early-Onset (EO) cases. A total of 88 patients from Italy (n = 52) and the Netherlands (n = 36), with a disease onset at age ≤ 45 years old and a Pain Numerical Rating Score ≥ 4, were recruited. After variant filtering and classification, WES analysis identified 142 potentially causative variants in 93 genes; 8 are Pathogenic, 15 are Likely Pathogenic, and 119 are Variants of Uncertain Significance. Notably, an enrichment of variants in transient receptor potential genes was observed, suggesting their role in pain modulation alongside VGSCs. A pathway analysis performed by comparing EO cases with 40 Italian healthy controls found enriched mutated genes in the “Nicotinic acetylcholine receptor signaling pathway”. Targeting this pathway with non-opioid drugs could offer novel therapeutic avenues for painful SFN. Additionally, with this study we demonstrated that employing a gene panel of reported mutated genes could serve as an initial screening tool for SFN in genetic studies, enhancing clinical diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Human Genetics of Neurological Disorders, IRCCS San Raffaele Scientific Institute, Institute of Experimental Neurology, 20132 Milan, Italy.
- Department of Toxicogenomics, Maastricht University, 6229 ER Maastricht, The Netherlands.
- Department of Neurology, Mental Health and Neuroscience Research Intsitute, Maastricht University Medical Centre+, 6229 ER Maastricht, The Netherlands.
- Department of Clinical Genetics, Maastricht University Medical Centre+, 6229 HX Maastricht, The Netherlands.
- Neuroalgology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
- Aldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
ORCID-Profile: Milena Ślęczkowska, Monique M Gerrits, Margherita Marchi, Janneke G J Hoeijmakers, Filippo Giovanni Martinelli Boneschi, Massimo Filippi, Catharina G Faber
Förderung
- Molecule-to-Man Pain Network, a European Commission Multi-Center Collaborative Projects through the European Union's Horizon 2020 research and innovation progr…
- European Union seventh framework program for the PROPANE study
- Italian Ministry of Health
- Molecule-to-Man Pain Network, a European Commission Multi-Center Collaborative Projects through the European Union’s Horizon 2020 research and innovation progr…
Zitieren
APA
Misra, K., Ślęczkowska, M., Santoro, S., Gerrits, M. M., Mascia, E., Marchi, M., Salvi, E., Smeets, H. J. M., Hoeijmakers, J. G. J., Martinelli Boneschi, F. G., Filippi, M., Lauria Pinter, G., Faber, C. G., & Esposito, F. (2024). Broadening the Genetic Spectrum of Painful Small-Fiber Neuropathy through Whole-Exome Study in Early-Onset Cases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137248
Vancouver
Misra K, Ślęczkowska M, Santoro S, Gerrits MM, Mascia E, Marchi M, et al. Broadening the Genetic Spectrum of Painful Small-Fiber Neuropathy through Whole-Exome Study in Early-Onset Cases. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137248
BibTeX
@article{Misra2024,
author = {Misra, Kaalindi and Ślęczkowska, Milena and Santoro, Silvia and Gerrits, Monique M and Mascia, Elisabetta and Marchi, Margherita and Salvi, Erika and Smeets, Hubert J M and Hoeijmakers, Janneke G J and Martinelli Boneschi, Filippo Giovanni and Filippi, Massimo and Lauria Pinter, Giuseppe and Faber, Catharina G and Esposito, Federica},
title = {Broadening the Genetic Spectrum of Painful Small-Fiber Neuropathy through Whole-Exome Study in Early-Onset Cases},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137248}
}
EUVIMED